Product Information
NIFEDIPINE 20 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.6856 per EA under NDC 62135074090. Its NADAC has been published 134 times since Mar 13, 2024.
FDA first approved this application on Apr 25, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Chartwell RX LLCNDC
62135074090
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NIFEDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA202644FDA Approved
4/25/2013
TE Code
AB
On Market Since
12/7/2010
Pharmacological Classes
Price Statistics
The NADAC for NIFEDIPINE 20 MG CAPSULE has been published 134 times since Mar 13, 2024, and over the history we have for it it has risen 23.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6856 per EA |
|---|---|
| All-time high | $0.7225 (Jun 11, 2025) |
| All-time low | $0.4474 (Nov 20, 2024) |
| 52-week high | $0.6856 |
| 52-week low | $0.5071 |
| Median price | $0.6183 |
| Average price | $0.6075 |
| Largest weekly change | -19.1% (Nov 20, 2024) |
| Weeks tracked | 134 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nifedipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIFEDIPINE 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NIFEDIPINE 20 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.6856 per EA (NDC 62135074090), effective Sep 30, 2026.
How has the price of NIFEDIPINE 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NIFEDIPINE 20 MG CAPSULE has risen 23.0%. It has been tracked across 134 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for NIFEDIPINE 20 MG CAPSULE?
Since Mar 13, 2024, the NADAC for NIFEDIPINE 20 MG CAPSULE has ranged from a low of $0.4474 (Nov 20, 2024) to a high of $0.7225 (Jun 11, 2025), with a median of $0.6183 per EA.
Are there cheaper alternatives to NIFEDIPINE 20 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NIFEDIPINE 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures NIFEDIPINE 20 MG CAPSULE?
NIFEDIPINE 20 MG CAPSULE (NDC 62135074090) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.